You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK (GenomeWeb) – Piper Jaffray has downgraded shares of Quidel to a Neutral rating from Overweight, citing the "limited upside" the company is likely to see in the 2016-2017 flu season.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.
This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.
Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.